Format

Send to

Choose Destination
Rev Alerg Mex. 2019 Apr-Jun;66(2):192-204. doi: 10.29262/ram.v66i2.591.

[Epidemiological study on atopic dermatitis in Mexico].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Ciudad de México, México. dianaaherrera@outlook.com.

Abstract

in English, Spanish

BACKGROUND:

There is limited epidemiological information on the treatment of atopic dermatitis (AD) from specialist physicians in Mexico.

OBJECTIVE:

To know the criteria that is used by specialists in Mexico to diagnose and treat AD.

METHODS:

An observational, descriptive and cross-sectional study, which was authorized by the ethics committee, was carried out through an electronic survey.

RESULTS:

114 surveys were carried out; 56% of the participants were allergists, 38% were dermatologists and 5% were pediatricians. It was identified that 54% used clinical criteria for the diagnosis of AD and 42% used the criteria of Hanifin-Rajka as a diagnostic complement; 38% requested total and/or specific IgE, blood biometry and blood chemistry tests. They recount that 90% of patients under the age of 18 had mild AD, 8% had moderate AD and 2% had severe AD; and, in patients over the age of 18, 89% had mild AD, 6% had moderate AD and 5% had severe AD. The patients' care was multidisciplinary, since 57% of the survey respondents requested assessments combined with ophthalmology, dermatology and allergology.

CONCLUSION:

Knowledge of the disease will lead to a better control of the disease. The challenge is to have a patient registry, update treatment guidelines, consider comorbidities and have therapeutic options for its control.

KEYWORDS:

Atopic dermatitis; Eczematous skin diseases; Epidemiology

PMID:
31200418
DOI:
10.29262/ram.v66i2.591

Supplemental Content

Loading ...
Support Center